Fogran Tablet 100 mg (Sofosbuvir Hydrochloride)
Sarpogrelate Hydrochloride
Prescription medication
iWorld Pharmaceutical Co., Ltd.
MFDS item code 201801412 · Approved 2018.03.30
This product's status changed to Expired on 2023.03.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of ischemic symptoms such as chronic arterial occlusive disease (ulcer, pain, etc.)
This medication is used to improve ischemic symptoms, including ulcers, pain, and cold sensations due to chronic arterial occlusive disease. It helps alleviate issues related to vascular diseases such as Buerger's disease, obstructive arteriosclerosis, and diabetic peripheral vascular disease. Patients should understand that this medication aids in improving blood flow in peripheral vessels, thereby effectively managing pain and symptoms. Therefore, it is useful for improving and treating various ischemic symptoms caused by narrowed blood vessels.
Administer 100 mg of Sofosbuvir Hydrochloride orally three times a day after meals. Adjust dosage as needed based on symptoms.
This medication should not be used in patients with bleeding, as it may increase the risk of bleeding. It is safe not to administer to pregnant women or women who may become pregnant. Patients who are menstruating or have a tendency to bleed, as well as those taking anticoagulants or platelet aggregation inhibitors, should use with caution due to an increased risk of bleeding. Patients with severe renal impairment or the elderly may experience difficulties in drug elimination, so caution is needed. During use, serious side effects such as bleeding symptoms, liver function abnormalities, and hematological disorders may occur, so regular blood tests and monitoring of conditions are necessary. Side effects such as skin rash, itching, vomiting, dyspepsia, palpitations, and drowsiness may occur, and if these symptoms arise, immediate consultation with medical personnel is required. The risk of bleeding may further increase if taken in conjunction with anticoagulants or platelet aggregation inhibitors, so caution is required when combining. Pregnant or nursing women are advised not to use this medication, and if it must be used, it is preferable to stop nursing. Safety in children has not been confirmed, so it is best to avoid use. The elderly are more likely to have impaired renal and liver function, so starting at a lower dose and closely monitoring conditions is advisable. This medication should be stored out of the reach of children, and it is important for safety and quality to avoid transferring it to other containers.
Bleeding tendency (gastrointestinal bleeding, cerebral hemorrhage, subcutaneous bleeding), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, respiratory distress
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for a long time.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sarpogrelate Hydrochloride
Prescription medication
iWorld Pharmaceutical Co., Ltd.
Sarpogrelate Hydrochloride
Prescription medication
Bionex Co., Ltd.
Sarpogrelate Hydrochloride
Prescription medication
AhnGuk New Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.